Your Dedicated Platform for ADC Toxicity Development to Foster New & Existing Relationships with Key Decision Makers Seeking Your Expertise
The 4th ADC Toxicity Summit is designed to address the most critical challenges in understanding, predicting, and mitigating safety risks across antibody–drug conjugate development.
Developed in close collaboration with ADC safety, toxicology, and translational experts, the summit focuses on enabling progress across key areas, including:
- Mechanistic drivers of ADC toxicity, including payload‑, linker‑, and target‑mediated liabilities
- Predictive non‑clinical models to improve preclinical‑to‑clinical safety translation
- Dose optimization strategies to widen the therapeutic window and reduce adverse events
- Biomarkers and translational tools to inform safety monitoring and clinical decision‑making
- Clinical safety management approaches, including mitigation and dose‑modification strategies
- Regulatory‑ready toxicology frameworks to support IND‑enabling and late‑stage development
Partner with us in 2026 to position your organization as a leader in ADC safety innovation and gain direct access to a highly targeted audience of senior toxicology, translational, and clinical development decision‑makers actively seeking new technologies, services, and strategic partnerships.
What to Expect
Mechanistic understanding of ADC toxicity, including on‑target/off‑tumor effects, payload‑driven toxicities, and linker‑related liabilities
Predictive non‑clinical safety strategies, spanning in vitro models, in vivo study design, and improved preclinical‑to‑clinical translation
Dose optimization and therapeutic window expansion, informed by PK/PD modeling, biomarkers, and clinical safety data
Clinical safety management, including adverse event monitoring, mitigation strategies, and dose modification frameworks
Regulatory‑ready safety packages, supporting IND‑enabling studies and global regulatory expectations
Translational integration, connecting toxicology, clinical pharmacology, and development decision‑making
Powering Innovation in ADC Toxicity Research
Attendees from leading biopharma and biotech organizations are actively seeking partners with expertise in ADC safety assessment, toxicology, translational modeling, and clinical risk mitigation strategies. Whether your focus is predictive non clinical safety models, dose optimization and PK/PD platforms, biomarker development, clinical safety management, or regulatory ready toxicology solutions, partnering with the 4th ADC Toxicity Summit connects you directly with the decision makers responsible for identifying, mitigating, and managing toxicity risks across ADC development.
This is where solution providers engage with the leaders shaping safer, more effective ADC pipelines, from preclinical evaluation through clinical translation.
1. CDMOs
ADC developers urgently need partners with proven expertise in linker chemistry, conjugation process development, and GMP-scale manufacturing. Showcase how your capabilities in site-specific conjugation, linker–payload integration, DAR control, and scalable conjugation workflows help translate innovative ADC designs from early discovery into robust, reproducible clinical and commercial production.
2. ADC Linker Synthesis & Raw Materials
Providers of specific components for linker synthesis and or services to synthesize said linkers
3. Conjugation technology / platform providers
Developers offering a proprietary conjugation methods such as site-specific chemistries, novel linkers, or enzymatic systems, designed to improve ADC performance and quality. Their value is in innovative IP, which biopharma partners license or adopt during discovery and early development.
Hear What Our Past Sponsors Have to Say
The size of the conference made networking relatively easy
HUB Organoids
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Nicholas Ramovic
Partnerships Director
4th ADC Toxicity Summit
Maintain Your Competitive Edge
Position yourself alongside other solution providers to ensure your brand is at the heart of biopharma discussions
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company’s goals